Combined protocols for the correction of unwanted hyperpigmentation in cosmetic patients
- Authors: Svechnikova E.V.1,2, Marshani Z.B1, Morzhanaeva M.A2
-
Affiliations:
- Polyclinic № 1 of the Department for Presidential Affairs of the Russian Federation
- Novosibirsk State Medical University
- Issue: Vol 29, No 8 (2022)
- Pages: 32-37
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/321040
- DOI: https://doi.org/10.18565/pharmateca.2022.8.32-37
- ID: 321040
Cite item
Open Access
Access granted
Abstract
Unwanted hyperpigmentation is one of the most common complaints of patients seeking cosmetic help. Currently, the possibilities of cosmetic correction and prevention of skin dyschromia are very diverse. To correct hyperpigmentation, it is necessary to use drugs and/or hardware procedures that can affect the regulation of melanin synthesis at different stages and levels; the mechanism of action, effectiveness and safety of this drugs aree confirmed not only by clinical, but also by laboratory research. This article presents the experience of using Meso-Xanthin F199® and IPL therapy in patients with unwanted hyperpigmentation.
Keywords
Full Text
About the authors
Elena V. Svechnikova
Polyclinic № 1 of the Department for Presidential Affairs of the Russian Federation; Novosibirsk State Medical University
Email: elene-elene@bk.ru
Dr. Sci. (Med.), Head of the Department of Dermatovenereology and Cosmetology; Professor of the Department of Dermatovenereology and Cosmetology Moscow, Russia; Novosibirsk, Russia
Z. B Marshani
Polyclinic № 1 of the Department for Presidential Affairs of the Russian FederationMoscow, Russia
M. A Morzhanaeva
Novosibirsk State Medical UniversityDepartment of Dermatovenereology and Cosmetology Novosibirsk, Russia
References
- Морозов С.Г., Волкова Е.Н., Григорьева А.А. и др. Экспериментальные доказательства влияния инъекционного препарата Meso-Xanthin F199® на меланогенез. Метаморфозы. 2017;17:60-4.
- Волкова Е.Н., Кожина К.В. и др. Meso-Xanthin F199™ в комплексном лечении акне и постакне. Les nouvelles esthetiques. 2017;10(2):22-5.
- Ашапкин В., Кутуева Л., Ванюшин Б. и др. Препарат Meso-Xanthin F199 и его роль в эпигенетическом механизме коррекции возрастных изменений кожи. Часть 1. Эстетическая медицина. 2013;12(4):459-68.
Supplementary files
